This page has some broken links, due to some issues with our hosting company. The issues should be fixed soon.—–
We have a page on Bayh-Dole march-in and royalty free cases here.
KEI efforts to address pricing and other public interest issues in more than 22 different NIH licensing cases, involving both patents and data rights, are here: http://keionline.org/nih-licenses
Our work on the Sanofi/Army Zika vaccine license is here. https://keionline.org/zika-army
Xtandi is an Army and NIH funded invention, patented by UCLA. Our work on the efforts to get the Army or the NIH to use their march-in or royalty free license rights to obtain lower prices are collected here: https://keionline.org/xtandi
The work on government funded CRISPR inventions is here: http://keionline.org/crispr
The Fabrazyme patent disputes are here: https://keionline.org/fabry
The 2004 and 2012 ritonavir cases are here: https://keionline.org/ritonavir
Many of the other disputes and commentary on government funded inventions are listed below.